© 2020 MJH Life Sciences and HCPLive. All rights reserved.
© 2020 MJH Life Sciences™ and HCPLive. All rights reserved.
September 28, 2020
Between 1999 and 2016, cardiovascular disease prevalence declined at a much faster for the highest-income earners than the rest of the population.
September 25, 2020
For obese patients, both weight gain and loss was linked to an increase in the rate of incident venous thromboembolism.
September 23, 2020
This decrease in hospital admissions had no association with regional prevalence of COVID-19.
September 21, 2020
Treatments for VTE in children fall short as they require frequent monitoring and include unpredictable food and drug interactions.
September 19, 2020
Individuals in vulnerable populations had a higher proportion and odds of not being vaccinated within the past year.
September 18, 2020
Ustekinumab should be prescribed cautiously to those at high cardiovascular risk.
September 17, 2020
Current therapies focus on relief of symptoms, but there is still an unmet need to address and target the molecular defects of hypertrophic cardiomyopathy.
Post-discharge thromboprophylaxis is not necessary.
The rate of adverse events was higher in patients suffering from both deep vein thrombosis and pulmonary embolisms than it was in just patients with DVT.
September 16, 2020
Lanthanum is commonly prescribed to CKD patients to help reduce the risk of bone and cardiovascular disease.